159 related articles for article (PubMed ID: 26081329)
1. [The results of the study of the efficacy and safety of mexidol in patients with chronic cerebral ischemia].
Chukanova EI; Chukanova AS; Mamayeva KI
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(2):71-74. PubMed ID: 26081329
[TBL] [Abstract][Full Text] [Related]
2. [The study of the efficacy and safety of Mexidol and Mexidol Forte 250 in patients with chronic cerebral ischemia].
Kutashov VA; Ulyanova OV
Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(12. Vyp. 2):89-92. PubMed ID: 32207723
[TBL] [Abstract][Full Text] [Related]
3. [Results of the sequential use of Mexidol and Mexidol Forte 250 in patients with chronic cerebral ischemia].
Abramenko YV
Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(3. Vyp. 2):59-64. PubMed ID: 32307432
[TBL] [Abstract][Full Text] [Related]
4. [Neurometabolic therapy of mild cognitive impairment in patients with chronic cerebral ischemia].
Antipenko EA; Shulyndin AV; Belyakov KM
Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(3):42-51. PubMed ID: 38529862
[TBL] [Abstract][Full Text] [Related]
5. [The efficacy and safety study of Mexidol and Mexidol FORTE 250 in patients with chronic cerebral ischemia].
Shchepankevich LA; Nikolaev YA; Taneeva EV; Pervuninskaya MA; Shchepankevich MS
Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(10):32-37. PubMed ID: 34874652
[TBL] [Abstract][Full Text] [Related]
6. [The assessment of the clinical efficacy, vasoactive and metabolic effects of mexidol in elderly patients with discirculatory encephalopathy].
Abramenko IuV
Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(11 Pt 1):35-41. PubMed ID: 22611676
[TBL] [Abstract][Full Text] [Related]
7. [Improving the effectiveness of pharmacotherapy in comorbid patients with chronic cerebral ischemia on an outpatient basis].
Vizilo TL; Arefieva EG
Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(3):51-55. PubMed ID: 36946397
[TBL] [Abstract][Full Text] [Related]
8. [The efficacy and safety of Mexidol Forte 250 as part of long-term sequential therapy in patients with carotid stroke].
Strelnikova IA; Svetkina AA; Androfagina OV
Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(3. Vyp. 2):54-58. PubMed ID: 32307431
[TBL] [Abstract][Full Text] [Related]
9. [The efficacy of combination therapy with mexidol and cerebrolysin in chronic cerebral ischemia].
Berezhnaya SV; Yakupov EZ; Zaharov YA
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(5):23-27. PubMed ID: 27240176
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy and safety of the drug mexidol FORTE 250 as part of sequential therapy in patients with chronic ischemia of the brain].
Chukanova EI; Chukanova AS
Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(9):39-45. PubMed ID: 31626217
[TBL] [Abstract][Full Text] [Related]
11. [Effectiveness and safety of mexidol forte 250 in the sequential therapy in patients with chronic ischemia].
Kataeva NG; Zamoshchina TA; Svetlik MV
Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(11):59-63. PubMed ID: 33340299
[TBL] [Abstract][Full Text] [Related]
12. [Possibilities of antioxidant therapy for asthenia and cognitive deficit in elderly patients with chronic brain ischemia].
Duma SN
Ter Arkh; 2013; 85(12):100-5. PubMed ID: 24640678
[TBL] [Abstract][Full Text] [Related]
13. [The neuroprotective therapy of outpatient treatment of chronic cerebral ischemia].
Berezhnaya SV; Yakupov EZ
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(6):48-52. PubMed ID: 26356397
[TBL] [Abstract][Full Text] [Related]
14. [Results of a cohort single-center randomized study of the modulating effect of the drug Mexidol in the rehabilitation of patients who suffered acute cerebral insufficiency].
Belkin AA; Belkin VA; Vasilchenko IE; Pinchuk EA
Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(4):108-117. PubMed ID: 38676685
[TBL] [Abstract][Full Text] [Related]
15. [Metabolic effects of mexidol in complex treatment of chronic brain ischemia].
Demchenko EIu; Kulakova NV; Semiglazova TA; Golovacheva AB; Borodulina EV; Udut VV
Eksp Klin Farmakol; 2008; 71(6):13-5. PubMed ID: 19140508
[TBL] [Abstract][Full Text] [Related]
16. [Possibilities of improving the effectiveness of therapy in patients with chronic cerebral ischemia against the background of COVID-19].
Kovalchuk VV; Ershova II; Molodovskaya NV
Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(3. Vyp. 2):60-66. PubMed ID: 33908234
[TBL] [Abstract][Full Text] [Related]
17. [Results of a randomized double blind multicenter placebo-controlled, in parallel groups trial of the efficacy and safety of prolonged sequential therapy with mexidol in the acute and early recovery stages of hemispheric ischemic stroke (EPICA)].
Stakhovskaya LV; Shamalov NA; Khasanova DR; Melnikova EV; Agafiina AS; Golikov KV; Bogdanov EI; Yakupova AA; Roshkovskaya LV; Lukinykh LV; Lokshtanova TM; Poverennova IE; Shepankevich LA
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(3. Vyp. 2):55-65. PubMed ID: 28665371
[TBL] [Abstract][Full Text] [Related]
18. [Results of an international multicenter, randomized, double-blind, placebo-controlled study assessing the efficacy and safety of sequential therapy with Mexidol and Mexidol FORTE 250 in patients with chronic brain ischemia (MEMO)].
Fedin AI; Zakharov VV; Tanashyan MM; Chukanova EI; Madzhidova EN; Shchepankevich LA; Ostroumova OD
Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(11):7-16. PubMed ID: 34932280
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of Mexidol in patients with chronic brain ischemia and cognitive impairment of different age groups (results of sub-analysis of the international multicenter, randomized, double-blind, placebo-controlled study of sequential therapy in patients with chronic brain ischemia MEMO)].
Zakharov VV; Tkacheva ON; Mkhitaryan EA; Fedin AI
Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(11. Vyp. 2):73-80. PubMed ID: 36412160
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy and safety of ethylmethylhydroxypyridine succinate in patients with chronic cerebral ischemia].
Zhuravleva MV; Prokofiev AB; Serebrova SY; Vasyukova NS; Demchenkova EY; Arkhipov VV
Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(6):119-124. PubMed ID: 32678558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
